Baoshan Cao Selected Research

Sorafenib (BAY 43-9006)

1/2021

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baoshan Cao Research Topics

Disease

11	Neoplasms (Cancer) 10/2022 - 08/2012
7	Adenocarcinoma of Lung 03/2022 - 02/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 08/2012
4	Lung Neoplasms (Lung Cancer) 07/2019 - 08/2012
3	Neoplasm Metastasis (Metastasis) 12/2021 - 10/2012
2	Pleural Effusion (Pleural Effusions) 03/2022 - 03/2019
1	COVID-19 10/2022
1	Mucositis 03/2022
1	Diarrhea 03/2022
1	Neutropenia 03/2022
1	Vomiting 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2022
1	Pain (Aches) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Necrosis 12/2020
1	Ischemia 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Hepatitis 01/2020
1	Radiation Injuries (Radiation Sickness) 07/2019
1	Hypoalbuminemia 07/2019
1	Venous Thromboembolism 07/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2019
1	Carcinogenesis 03/2014

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 03/2022 - 02/2014
5	Tyrosine Kinase InhibitorsIBA 12/2021 - 02/2014
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 06/2018 - 08/2012
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	Anaplastic Lymphoma KinaseIBA 03/2019 - 03/2014
2	Biological ProductsIBA 01/2017 - 08/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 12/2020
1	bicyclolIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Methylprednisolone FDA LinkGeneric 01/2020
1	Serum AlbuminIBA 07/2019
1	AlbuminsIBA 07/2019
1	fibrin fragment D (D-dimer)IBA 07/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2019
1	Indicators and Reagents (Reagents)IBA 06/2018
1	apatinibIBA 10/2017
1	Epithelial Cell Adhesion MoleculeIBA 09/2017
1	Gemcitabine FDA Link 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	Pemetrexed (MTA)FDA Link 02/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2015
1	taxaneIBA 02/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2015
1	Immunoglobulin G (IgG)IBA 02/2015
1	nimotuzumabIBA 02/2015
1	PlatinumIBA 10/2012
1	EndostatinsIBA 08/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 03/2022 - 10/2012
3	Therapeutics 01/2021 - 10/2017
2	Radiotherapy 12/2021 - 01/2013
1	Hand Hygiene 10/2022
1	Treatment Delay 10/2022
1	Immunotherapy 01/2020